Forecast Of The Day: Colgate-Palmolive’s Hill’s Pet Nutrition Revenues
What?
Trefis expects Colgate-Palmolive’s (NYSE:CL) Hill’s Pet Nutrition Revenues to increase from around $2.80 billion in 2020 to $3.10 billion in 2021 and to $3.33 billion in 2022.
Why?
- Should You Pick Colgate-Palmolive Stock Over Monster Beverage After The Latter’s 2x Gains This Year?
- Should You Pick Colgate-Palmolive Stock After A Q3 Beat And 4% Gains This Month?
- Is Colgate-Palmolive Stock A Better Pick Over Marriott?
- Which Is A Better Consumer Defensive Pick – Kimberly-Clark Or CL Stock?
- Should You Buy Colgate-Palmolive Stock At $80?
- Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?
Pet ownership has soared through the Covid-19 related lockdowns and we expect this to bode well for the sales of pet nutrition products.
So What?
Hill’s has been the key driver of Colgate’s revenue growth in recent years, and if the segment outperforms, there could be some upside to Colgate stock, which has remained roughly flat year-to-date.
See Our Complete Analysis For Colgate-Palmolive
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market since 2016
See all Trefis Price Estimates and Download Trefis Data here
What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams